|Articles|September 1, 2011
- BioPharm International-09-02-2011
- Volume 2011 Supplement
- Issue 6
BioPharm International, September 2011 Supplement (PDF)
Biopharmaceutical Trends Report
Advertisement
Articles in this issue
over 14 years ago
Q&A with Francis S. Collinsover 14 years ago
Single-use Technology: Balancing the Risks and Rewardsover 14 years ago
Challenges and Innovations with Prefilled Syringesover 14 years ago
Trends in Prefillsover 14 years ago
Perception and Costs of Biotech Innovationover 14 years ago
Navigating the Biosimilars MarketNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
2
Generative AI and Adaptive Trials Shape Future Biotech Development
3
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
4
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
5